MetaCap

Phathom Pharmaceuticals (PHAT) Stock Chart

NASDAQ: PHATHealth CareBiotechnology: Pharmaceutical PreparationsUSD

4.66-0.42 (-8.27%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

PHAT technical summary

PHAT is trading 29.5% below its 50-day simple moving average of $6.61 and 52.6% below its 200-day average of $9.82. The 50-day average is below the 200-day average, a configuration technical analysts associate with a longer-term downtrend. The 14-day Relative Strength Index (RSI) is 31.1, within the neutral 30 to 70 band.

Over the past year, the stock ranged from $4.62 (Nov 20, 2026) to $18.31 (Dec 23, 2025); the current price is at the bottom of that range. Annualized 30-day volatility is 98.0%. Based on the last session's high, low and close, the classic pivot point is $4.81, with first resistance at $5.00 and first support at $4.47.

These indicators describe past price behavior for Phathom Pharmaceuticals; they are not predictions.

Summary generated from market data by MetaCap's automated system. Methodology

Technical indicators

Beta
—
1Y high
18.31 (Dec 23)
1Y low
4.62 (Nov 20)
Last close
4.66

PHAT price performance

1 week

-23.10%

1 month

-33.71%

3 months

-47.46%

6 months

-58.87%

Year to date

-71.91%

1 year

-68.93%

3 years

-37.03%

5 years

-76.46%

PHAT price return, excluding dividends.

Moving averages

Simple and exponential moving averages
PeriodSimple (SMA)Exponential (EMA)
5-day5.28Price below5.18Price below
10-day5.58Price below5.43Price below
20-day5.68Price below5.75Price below
50-day6.61Price below6.64Price below
100-day8.25Price below7.88Price below
200-day9.82Price below9.80Price below

Moving averages are computed from daily closing prices over the past year. What is a moving average?

Pivot points

Classic pivot points
LevelPrice
Resistance 3 (R3)5.53
Resistance 2 (R2)5.34
Resistance 1 (R1)5.00
Pivot point4.81
Support 1 (S1)4.47
Support 2 (S2)4.28
Support 3 (S3)3.94

Classic floor-trader pivots from the last session's high, low and close. How pivot points work

Learn technical analysis